Great question. While Amazon unveiled a partially-telehealth offering in November (through their acquisition of One Medical), this is an Amazon Prime add-on subscription service for primary care and operates through insurance. This is very different from Hims' DTC business model offering free physician appointments for prospective and existing Hims subscribers. I expect Amazon to face challenges with their healthcare offering as it would take a complete overhaul to match that of Hims. Building a trusted brand in this space is also extremely difficult. In short, I don't see Hims as having any 1:1 competition today for these reasons and those discussed in the article.
Thanks for the writeup. Intriguing company. If you compare the products HIMs sells versus whats available on Cost+ drugs, HIMs is sometimes 2-3x more expensive. I get the convenience factor, but after a while won't customers churn they know what they want and find it cheaper elsewhere? Even the personalized products are generics (if im not wrong) . But I've spent about 1 hour looking at this , so am probably missing something.
Do you see Amazon has their competitor and can they beat Amazon.
Great question. While Amazon unveiled a partially-telehealth offering in November (through their acquisition of One Medical), this is an Amazon Prime add-on subscription service for primary care and operates through insurance. This is very different from Hims' DTC business model offering free physician appointments for prospective and existing Hims subscribers. I expect Amazon to face challenges with their healthcare offering as it would take a complete overhaul to match that of Hims. Building a trusted brand in this space is also extremely difficult. In short, I don't see Hims as having any 1:1 competition today for these reasons and those discussed in the article.
Thanks for the writeup. Intriguing company. If you compare the products HIMs sells versus whats available on Cost+ drugs, HIMs is sometimes 2-3x more expensive. I get the convenience factor, but after a while won't customers churn they know what they want and find it cheaper elsewhere? Even the personalized products are generics (if im not wrong) . But I've spent about 1 hour looking at this , so am probably missing something.
Let’s partner! I would love to write a co-published article with you. I write about FinTech Stocks and their value prop! Take a look:
https://substack.com/@fintechdd?r=5j76ba&utm_medium=ios&utm_source=edit-profile
Good
https://open.substack.com/pub/fjresearch/p/why-im-all-in-on-hims-and-hers-health?r=5fdf2w&utm_medium=ios